Paul J. Lytle

2019

In 2019, Paul J. Lytle earned a total compensation of $257.7K as Former Chief Financial Officer at Peregrine Pharmaceuticals, a 44% decrease compared to previous year.

Compensation breakdown

Salary$37,440
Other$220,223
Total$257,663

Lytle received $220.2K in other compensation, accounting for 85% of the total pay in 2019.

Lytle also received $37.4K in salary.

Rankings

In 2019, Paul J. Lytle's compensation ranked 13,180th out of 13,971 executives tracked by ExecPay. In other words, Lytle earned more than 5.7% of executives.

ClassificationRankingPercentile
All
13,180
out of 13,971
6th
Division
Manufacturing
5,363
out of 5,701
6th
Major group
Chemicals And Allied Products
2,094
out of 2,200
5th
Industry group
Drugs
1,797
out of 1,886
5th
Industry
Pharmaceutical Preparations
1,328
out of 1,398
5th

Pay ratio

Paul J. Lytle's Pay$257,663
Median Employee's Pay$96,570
Pay Ratio

3

to 1

In 2019, the annual total compensation of Paul J. Lytle was $257,663.

The annual total compensation of the median employee at Peregrine Pharmaceuticals was $96,570.

The ratio of Paul J. Lytle's pay to the pay of median employee was therefore 3 to one.

Source: SEC filing on August 21, 2019.

Lytle's colleagues

We found four more compensation records of executives who worked with Paul J. Lytle at Peregrine Pharmaceuticals in 2019.

2019

Roger Lias

Peregrine Pharmaceuticals

Chief Executive Officer

2019

Daniel Hart

Peregrine Pharmaceuticals

Chief Financial Officer

2019

Mark Ziebell

Peregrine Pharmaceuticals

General Counsel

2019

Stephen Hedberg

Peregrine Pharmaceuticals

Principal Financial Officer and Principal Accounting Officer

News

You may also like